| 综述 |
|
|
|
|
| 分子探针在细胞凋亡检测中的研究进展 |
| 唐敏1,3, 曾文彬2,3, 曹亚1,3 |
1. 中南大学肿瘤研究所 长沙 410078;
2. 中南大学药学院 长沙 410013;
3. 中南大学分子影像研究中心 长沙 410078 |
|
| Progress in Molecular Probe for the Detection of Apoptosis |
| TANG Min1,3, ZENG Wen-bin2,3, CAO Ya1,3 |
1. Cancer Research Institute, Central South University, Changsha 410078, China;
2. School of Pharmaceutical Sciences, Central South University, Changsha 410013, China;
3. Molecular Imaging Research Center, Central South University, Changsha 410078, China |
| [1] Reed J C. Apoptosis-based therapies. Nat Rev Drug Discov, 2002, 1: 111-121.
[2] Taylor R C, Cullen S P, Martin S J. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol, 2008, 9: 231-241.
[3] Weissleder R. Molecular imaging in cancer. Science, 2006, 312: 1168-1171.
[4] 申宝忠. 分子影像学. 北京: 人民卫生出版社, 2007. Shen B Z. Molecular Imaging. 1sted. Beijing: People's Medical Publishing House, 2007.
[5] Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell, 2009, 138: 838-854.
[6] Nguyen Q D, Smith G, Glaser M, et al. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific -labeled isatin sulfonamide. Proc Natl Acad Sci U S A, 2009, 106: 16375-16380.
[7] Hickson J, Ackler S, Klaubert D, et al. Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death Differ, 2010, 17: 1003-1010.
[8] Edgington L E, Berger A B, Blum G, et al. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med, 2009, 15: 967-973.
[9] Jun Y W, Sheikholeslami S, Hostetter D R, et al. Continuous imaging of plasmon rulers in live cells reveals early-stage caspase-3 activation at the single-molecule level. Proc Natl Acad Sci U S A, 2009, 106: 17735-17740.
[10] Boersma H H, Kietselaer B L, Stolk L M, et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med, 2005, 46: 2035-2050.
[11] Blankenberg F G. Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V. Proc Am Thorac Soc, 2009, 6: 469-476.
[12] 王荣福, 刘萌, 张春丽, et al. 单次化疗后荷瘤小鼠肿瘤细胞凋亡显像研究. 中国医学影像技术, 2005, 21: 1667-1670. Wang R F, Liu M, Zhang C L, et al. Chinese Journal of Medical Imaging Technilogy, 2005, 21(11):1167-1670.
[13] Kenis H, Zandbergen H R, Hofstra L, et al. Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging. J Nucl Med, 2010, 51: 259-267.
[14] Hoebers F J, Kartachova M, de Bois J, et al. 99 mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging, 2008, 35: 509-518.
[15] Ntziachristos V, Schellenberger E A, Ripoll J, et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A, 2004, 101: 12294-12299.
[16] Damianovich M, Ziv I, Heyman S N, et al. ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging, 2006, 33: 281-291.
[17] Aloya R, Shirvan A, Grimberg H, et al. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis, 2006, 11: 2089-2101.
[18] Shirvan A, Reshef A, Yogev-Falach M, et al. Molecular imaging of neurodegeneration by a novel cross-disease biomarker. Exp Neurol, 2009, 219: 274-283.
[19] Grimberg H, Levin G, Shirvan A, et al. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis, 2009, 14: 257-267.
[20] Reshef A, Shirvan A, Waterhouse R N, et al. Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med, 2008, 49: 1520-1528.
[21] Cohen A, Shirvan A, Levin G, et al. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res, 2009, 19: 625-637.
[22] Reshef A, Shirvan A, Akselrod-Ballin A, et al. Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med, 2010, 51: 837-840.
[23] Zeng W, Yao M L, Townsend D, et al. Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis. Bioorg Med Chem Lett, 2008, 18: 3573-3577.
[24] Zeng W, Miao W, Kabalka G, et al. Design, synthesis, and biological evaluation of a dansyled amino acid derivative as an imaging agent for apoptosis. Tetrahedron Letters, 2008, 49: 6429-6432.
[25] Zeng W, Miao W, Le Puil M, et al. Design, synthesis, and biological evaluation of 4-(5-dimethylamino-naphthalene-1-sulfon-amido)-3-(4-iodophenyl)butanoic acid as a novel molecular probe for apoptosis imaging. Biochem Biophys Res Commun, 2010, 398: 571-575.
[26] Zhang X, Paule M G, Newport G D, et al. MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH. J Neural Transm, 2010,118(2):203-211. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
